Detalhe da pesquisa
1.
Complement Inhibitors in the Management of Complement-Mediated Hemolytic Uremic Syndrome and Paroxysmal Nocturnal Hemoglobinuria.
Am J Ther
; 30(3): e209-e219, 2023 May 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37104648
2.
Gilteritinib clinical activity in relapsed/refractory FLT3 mutated acute myeloid leukemia previously treated with FLT3 inhibitors.
Am J Hematol
; 97(3): 322-328, 2022 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34981560
3.
Poor Outcome of Adult T-Cell Leukemia/Lymphoma with Current Available Therapy: An Experience of Two Centers.
Oncol Res Treat
; 46(11): 459-465, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37844559
4.
Lrp-DNA complex stability determines the level of ON cells in type P fimbriae phase variation.
Mol Microbiol
; 81(5): 1286-99, 2011 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-21752106
5.
Use of Mogamulizumab for Cutaneous Adult T-cell Leukemia in a Patient Living With HIV.
Cureus
; 14(11): e31701, 2022 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-36561586